Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;10(2):183-189.
doi: 10.1002/alr.22454. Epub 2019 Oct 10.

Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps

Affiliations

Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps

Sonya Marcus et al. Int Forum Allergy Rhinol. 2020 Feb.

Abstract

Background: Central compartment atopic disease (CCAD) is a recently described variant of chronic rhinosinusitis with nasal polyp (CRSwNP) associated with inhalant allergy. An association with asthma was noted to be uncommon within our clinical practice. The purpose of this study was to determine allergy and asthma prevalence in CCAD and other CRSwNP subtypes.

Methods: A retrospective analysis at a tertiary care institution was performed over the period from 2015 to 2019. CRSwNP was grouped into the following subtypes: allergic fungal rhinosinusitis (AFRS); aspirin-exacerbated respiratory disease (AERD); CCAD; and CRSwNP not otherwise specified (CRSwNP NOS). Patients with sinonasal polyps and concomitant polypoid disease in the central compartment (CRSwNP/CC) were analyzed as a separate cohort for the purpose of this study. Prevalence of allergy and asthma was compared between groups.

Results: Three hundred fifty-six patients were included. CRSwNP NOS was the most common subtype (37.1%) and CRSwNP/CC was the least common (3.7%), with other CRS subtypes ranging between 11.5% and 24.2%. Asthma prevalence was highest in AERD (100%) and CRSwNP NOS (37.1%), but substantially lower in AFRS (19.0%) and CCAD (17.1%). Asthma was significantly more common in AERD and CRSwNP NOS when compared with CCAD (p < 0.001 and p = 0.039, respectively). Prevalence of allergy was significantly higher in AFRS (100%), CCAD (97.6%), CRSwNP/CC (84.6%), and AERD (82.6%) when compared with CRSwNP NOS (56.1%) (p < 0.001).

Conclusion: CCAD represents a clinically distinct phenotype of CRSwNP with a high prevalence of allergy and low prevalence of asthma. Patients with both CCAD and diffuse sinonasal polyps had an allergy prevalence approaching that of CCAD and an asthma prevalence approaching CRSwNP NOS.

Keywords: allergy; asthma; central compartment atopic disease; chronic rhinosinusitis; nasal polyposis.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
CT scans demonstrating: (A) isolated CCAD and (B) CRSwNP/CC. CCAD = isolated central compartment atopic disease; CRSwNP = chronic rhinosinusitis with nasal polyposis; CRSwNP/CC = chronic rhinosinusitus with sinonasal polyps and central compartment involvement; CT = computed tomography.
FIGURE 2.
FIGURE 2.
Prevalence of allergy in the CRSwNP subtypes. AERD = aspirin-exacerbated respiratory disease; AFRS = allergic fungal rhinosinusitis; CCAD = isolated central compartment atopic disease; CRSwNP NOS = chronic rhinosinusitis with nasal polyposis, not otherwise specified; CRSwNP/CC denotes those with sinonasal polyps and central compartment involvement. Connecting lines represent statistically significant differences between groups (p < 0.05).
FIGURE 3.
FIGURE 3.
Prevalence of asthma in the CRSwNP subtypes. AERD = aspirin-exacerbated respiratory disease; AFRS = allergic fungal rhinosinusitis; CCAD = isolated central compartment atopic disease; CRSwNP/CC = sinonasal polyps and central compartment involvement. CRSwNP NOS = chronic rhinosinusitis with nasal polyposis, not otherwise specified. Connecting lines represent statistically significant differences between groups (p < 0.05).

References

    1. Anand V Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. 2004;113:3–5. - PubMed
    1. Succar EF, Turner JH. Recent advances in understanding chronic rhinosinusitis endotypes. F1000Res. 2018;7. - PMC - PubMed
    1. Grayson JW, Cavada M, Harvey RJ. Clinically relevant phenotypes in chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2019;48:23:1–7. - PMC - PubMed
    1. White LJ, Rotella MR, DelGaudio JM. Polypoid changes of the middle turbinate as an indicator of atopic disease. Int Forum Allergy Rhinol. 2014;4:376–380. - PubMed
    1. Hamizan AW, Christensen JW, Ebenzer J, et al. Middle turbinate edema as a diagnostic marker of inhalant allergy. Int Forum Allergy Rhinol. 2016;7:37–42. - PubMed

Publication types